179 related articles for article (PubMed ID: 28895263)
1. Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase.
Chellat MF; Riedl R
Angew Chem Int Ed Engl; 2017 Oct; 56(43):13184-13186. PubMed ID: 28895263
[TBL] [Abstract][Full Text] [Related]
2. Discovery, properties, and biosynthesis of pseudouridimycin, an antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase.
Maffioli SI; Sosio M; Ebright RH; Donadio S
J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):335-343. PubMed ID: 30465105
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide-Modified Analogues.
Anwar AF; Cain CF; Garza MJ; Degen D; Ebright RH; Del Valle JR
ChemMedChem; 2024 Jan; 19(1):e202300474. PubMed ID: 37751316
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.
Maffioli SI; Zhang Y; Degen D; Carzaniga T; Del Gatto G; Serina S; Monciardini P; Mazzetti C; Guglierame P; Candiani G; Chiriac AI; Facchetti G; Kaltofen P; Sahl HG; Dehò G; Donadio S; Ebright RH
Cell; 2017 Jun; 169(7):1240-1248.e23. PubMed ID: 28622509
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Pseudouridimycin Biosynthetic Pathway Provides Insights into the Formation of C-nucleoside Antibiotics.
Sosio M; Gaspari E; Iorio M; Pessina S; Medema MH; Bernasconi A; Simone M; Maffioli SI; Ebright RH; Donadio S
Cell Chem Biol; 2018 May; 25(5):540-549.e4. PubMed ID: 29551347
[TBL] [Abstract][Full Text] [Related]
6. Aminoribosylated Analogues of Muraymycin Nucleoside Antibiotics.
Wiegmann D; Koppermann S; Ducho C
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486316
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Nucleoside Natural Products Inhibiting Phospho-MurNAc-Pentapeptide Translocase; Chemistry and Structure-Activity Relationship.
Ichikawa S; Yamaguchi M; Matsuda A
Curr Med Chem; 2015; 22(34):3951-79. PubMed ID: 26282943
[TBL] [Abstract][Full Text] [Related]
8. Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores.
Patel B; Kerr RV; Malde AK; Zunk M; Bugg TDH; Grant G; Rudrawar S
ChemMedChem; 2020 Aug; 15(15):1429-1438. PubMed ID: 32476294
[TBL] [Abstract][Full Text] [Related]
9. Novel RNA polymerase inhibitor found in soil extracts provides hope for future antibacterial drugs.
Ebright RH
Future Med Chem; 2017 Oct; 9(16):1857-1861. PubMed ID: 29076390
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of antibiotics inhibiting bacterial RNA polymerase.
Mosaei H; Harbottle J
Biochem Soc Trans; 2019 Feb; 47(1):339-350. PubMed ID: 30647141
[TBL] [Abstract][Full Text] [Related]
11. Chemical logic and enzymatic machinery for biological assembly of peptidyl nucleoside antibiotics.
Walsh CT; Zhang W
ACS Chem Biol; 2011 Oct; 6(10):1000-7. PubMed ID: 21851099
[TBL] [Abstract][Full Text] [Related]
12. Natural Products at Work: Structural Insights into Inhibition of the Bacterial Membrane Protein MraY.
Koppermann S; Ducho C
Angew Chem Int Ed Engl; 2016 Sep; 55(39):11722-4. PubMed ID: 27511599
[TBL] [Abstract][Full Text] [Related]
13. Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit.
Heib A; Niro G; Weck SC; Koppermann S; Ducho C
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861655
[TBL] [Abstract][Full Text] [Related]
14. Characterization of C-nucleoside Antimicrobials from Streptomyces albus DSM 40763: Strepturidin is Pseudouridimycin.
Rosenqvist P; Palmu K; Prajapati RK; Yamada K; Niemi J; Belogurov GA; Metsä-Ketelä M; Virta P
Sci Rep; 2019 Jun; 9(1):8935. PubMed ID: 31222036
[TBL] [Abstract][Full Text] [Related]
15. A detailed study of antibacterial 3-acyltetramic acids and 3-acylpiperidine-2,4-diones.
Jeong YC; Bikadi Z; Hazai E; Moloney MG
ChemMedChem; 2014 Aug; 9(8):1826-37. PubMed ID: 24838989
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of simplified side chains of the macrolide antibiotic etnangien.
Altendorfer M; Irschik H; Menche D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5731-4. PubMed ID: 22832317
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Medicinal Chemistry of Muraymycins, Nucleoside Antibiotics.
Katsuyama A; Ichikawa S
Chem Pharm Bull (Tokyo); 2018; 66(2):123-131. PubMed ID: 29386462
[TBL] [Abstract][Full Text] [Related]
18. Microbes, not humans: exploring the molecular basis of Pseudouridimycin selectivity towards bacterial and not human RNA polymerase.
Rabbad AH; Agoni C; Olotu FA; Soliman ME
Biotechnol Lett; 2019 Jan; 41(1):115-128. PubMed ID: 30377869
[TBL] [Abstract][Full Text] [Related]
19. Concise synthesis and antibacterial evaluation of novel 3-(1,4-disubstituted-1,2,3-triazolyl)uridine nucleosides.
Tachallait H; Bouyahya A; Talha A; Bakri Y; Dakka N; Demange L; Benhida R; Bougrin K
Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800204. PubMed ID: 30276854
[TBL] [Abstract][Full Text] [Related]
20. Novel synthetic molecules targeting the bacterial RNA polymerase assembly.
André E; Bastide L; Michaux-Charachon S; Gouby A; Villain-Guillot P; Latouche J; Bouchet A; Gualtiéri M; Leonetti JP
J Antimicrob Chemother; 2006 Feb; 57(2):245-51. PubMed ID: 16373430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
